TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review January 29, 1988
TCL Archive Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds June 29, 2007
Primary Source Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia May 6, 2021
